For over two decades, we have innovated pharmaceutical and biopharmaceutical sciences believing that a drug delayed is a drug denied. Now we are making available our wisdom, our technology and our passion to help you get to market fast, whether you are working on a simple generic, a complex generic, a biosimilar or a new biologic. Let us show how we can help you get to market faster without any obligation to you.

Our vision

Provider of science-smart strategy for regulatory approval of complex, high value products.

Mission

Using our proprietary, patented and time-tested portfolio of strategies to reduce the COGS; we operate in a virtual environment.

goals

Reach out to pharmaceutical and biopharmaceutical developers to show how outsourcing allows unlimited expansion of product portfolio.

objectives

Creating a demonstratable model of virtual development--we have already collected stake-holders.

OUR MODEL

Unique to the industry, we have developed a science-base mode for the development of new drugs and biologics, as well as generics and biosimilars. 

To create a science-based fast to market path for drug approval. The regulatory agencies have come a long way in accepting scientific wisdom, the developers have not yet. Our proprietary and patented technology can help you set up a new facility at a fraction of cost, anticipate and meet expectations of regulatory agencies, create novel formulations, and create an acceptable submission package in the shortest time.


Non-linear thinking is not natural to human thought; it takes an outside pointer to direct traditional understanding towards the new science.
— Sarfaraz K. Niazi, Ph.D., Pharmaceutical and Biopharmaceuticsl Sciences Pioneer, Author and Inventor.

What We've Achieved